Local removal for early rectal cancer without extra treatment
Part of Cancer, Digestive system clinical trials.
This trial studies removing an early rectal cancer tumor locally (through the rectum/anal area) with no additional therapy afterward. The goal is to preserve organs and maintain quality of life while still trying to cure the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your tumor is rectal cancer of a specific type: adenocarcinoma
- Your tumor is early stage: cT1N0M0 (no spread to lymph nodes or distant organs)
- The tumor is small and low in the rectum: up to 3 cm wide, and within 2 cm of the anal opening
- Your scans and/or scope findings suggest the tumor is only in the top sub-layer (not into the muscle layer)
- You are not planning additional treatments like combined chemo and radiation after local removal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial tests a strategy to avoid surgery by using watchful waiting after initial treatment for early-stage rectal cancer. It may help patients keep their rectum and avoid a permanent colostomy.
This trial is studying different treatments for patients with early-stage rectal cancer that has a higher chance of coming back after local removal. It looks at whether adding radiation or chemoradiation after local surgery can improve outcomes.
This Phase 2 trial tests a “total neoadjuvant” treatment plan (medicine given before surgery) that may help some people avoid or reduce surgery for very low rectal cancer. It aims to improve the chance of keeping more normal function while still treating the cancer safely.
This trial is testing whether a more limited surgery for mid and low rectal cancer can be safe, by avoiding removal of lymph nodes near the main artery. It may be a good fit if your tumor is in the lower rectum, hasn't spread far, and you are in generally good health.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.